The ABPI is delighted to announce the appointment of Professor Carole Longson MBE as Chief Scientific Officer at the Association of the British Pharmaceutical Industry (ABPI). Carole joins the ABPI from her current role as Executive Director and Board Member at the National Institute for Health and...
As the new AMR Industry Alliance launches its first progress report, ABPI chief executive Mike Thompson welcome the industry’s willingness to work collaboratively to detect, prevent and control AMR.
As the MHRA publishes an update to pharmaceutical companies on preparing for Brexit, the ABPI reaffirms the importance of patient and public health in negotiations.
The ABPI have responded today to an announcement by the Department of Health & Social Care who have published a 12 week consultation seeking views from interested parties on the recommendations in the Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP).
On Wednesday 21 February, Health and Social Care Secretary Jeremy Hunt announced that Baroness Julia Cumberlege will lead a review into how the NHS responds to safety concerns raised by patients about medicines or medical devices.
The ABPI has responded to the Prime Minister's ‘Road to Brexit’ speech today at Mansion House.
The Association of the British Pharmaceutical Industry (ABPI) - representing leading global pharmaceutical businesses in the UK - have welcomed the EU Council's agreement to progress Brexit negotiations to the next phase and the EU Council's approval of a transition period.